Qube Research & Technologies (QRT)
COCH icon

Qube Research & Technologies (QRT)’s Envoy Medical COCH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,637
Closed -$6.42K – 3920
2024
Q1 		$6.42K Buy
+1,637
New +$4.79K ﹤0.01% 3858
2022
Q1 		– Sell
-20,282
Closed -$198K – 2516
2021
Q4 		$198K Buy
+20,282
New +$198K ﹤0.01% 1977

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

Qube Research & Technologies (QRT)'s COCH Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Envoy Medical (COCH) in Q2 2024, closing a stake of 1,637 shares — an estimated $6.42K sold.

Qube Research & Technologies (QRT) first reported a position in COCH in Q4 2021 and held it in 2 quarters. The position peaked at $198K in Q4 2021. 20 funds tracked by Wall St. Rank hold COCH as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Envoy Medical position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,637 Envoy Medical shares in Q2 2024, an estimated $6.42K.
  • Qube Research & Technologies (QRT) first reported a position in Envoy Medical in Q4 2021 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Envoy Medical position peaked at $198K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.